Navigation Links
US Court Allows Teva to Deliver Disputed Drug: Novartis

A US court has authorised Israeli generic medicines group Teva to resume deliveries of a blood pressure drug despite a patent lawsuit by Novartis, the Swiss pharmaceutical group said on Tuesday . A US federal court judge in New Jersey rejected on Monday a request from Novartis to stop Teva Pharmaceuticals from resuming shipments of generic versions of the drug, pending a trial in the case, the Swiss group said in a statement.

The court had halted new deliveries of the drug by Teva last month but not sales of stocks that had already been delivered to outlets beforehand. Novartis, which claims it still has a US patent on the drug -- which it markets as Lotrel -- until 2017, said it will continue pursuing its patent infringement lawsuit against Teva in the New Jersey court.

"Teva, which began selling a generic version of Lotrel in the US in May 2007, risks potentially significant damages if Novartis prevails in patent litigation," it added. Lotrel, which is sold only in the US, combines in a single capsule two active ingredients that individually no longer have US patent protection, Novartis said.

The drug had annual sales of 1.35 billion dollars in 2006. Novartis said it would release an evaluation of the potential impact of Teva's actions on full-year 2007 net sales, operating and net income results when it reports on first-half and second-quarter results on July 17.


'"/>




Page: 1

Related medicine news :

1. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
2. Bihar High Court Intervenes To End Doctors Strike
3. High Court Issues Notice To Centre On Smoking Ban In Films
4. Madras High Court Disapproves of Comparative Advertisements
5. Another British Woman In Court For New Breast Cancer Drug
6. Fizzy Logic For A Perfect Drink: Courtesy Boffins
7. Australian Court Finds Man Guilty of Spreading HIV/AIDS
8. Dare Not Mercy kill – Courtesy: The Care Not Killing Grou
9. Court Orders Private Hospitals To Provide Free Treatment For The Poor
10. Courting Couples Use Valentine’s Day Threat to Their Advantag
11. Mental Health Court Established
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ANN ARBOR, Mich. (PRWEB) , ... ... ... Global Retailer and Manufacturer Alliance (GRMA) is growing as it continues developing ... the dietary supplement industry. The organization, which plans to publish the first ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... oral braces. "The rubber bands used in conjunction with my braces always rubbed ... to design a way to prevent this problem." The O.B.S. was the result ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly ... assembly protocols involve many repetitive steps and often scientists require many different versions ... high-throughput needed, and results in a lower error rate and cost saving for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Novartis announced today ... has accepted the company,s Biologics License Application (BLA) ... an investigational chimeric antigen receptor T cell (CAR-T) ... young adult patients with B-cell acute lymphoblastic leukemia ... Novartis for a CAR-T. The priority review designation ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "South ... & Forecast" report to their offering. ... The South Korean Proton Therapy Market is expected to ... Untapped Proton Therapy Market for South Korea was ... Proton Therapy plays an important role in delivering comprehensive cancer care to ...
(Date:3/29/2017)... 29, 2017  Zynex (OTCQB: ZYXI), an innovative medical technology ... medical devices for pain management, stroke rehabilitation, cardiac monitoring ... the Company,s 2016 full-year investor webcast on Monday, April 3, ... The Company expects to file its 2016 full year ... ...
Breaking Medicine Technology: